|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Presence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in blood donors poses a risk of transmission through blood transfusion. Chronic HBV and HCV infections put people at high risk of diseases with high morbidity and mortality. We wanted to estimate the seroprevalence of these infections in Northeast India by undertaking a study on the healthy blood donors. In a retrospective study we reviewed the records of blood donors from 2009 to 2013. The donors were screened for HBsAg by MICROSCREEN ELISA TEST KIT, Span Diagnostic Ltd and for anti-HCV by SD HCV ELISA 3.0, SD Bio Standard Diagnostics Pvt. Ltd respectively. A total of 136,116 donations were received, comprising of 60.92%voluntary donors and 39.07% replacement donors. 94.08% were males and 5.32% were females. The overall prevalence of HBsAg and anti-HCV positive blood donors was 0.77% and 0.37% respectively. The prevalence rates were higher in the replacement donors compared to the voluntary donors (p < 0.0001). There was decreasing trend in the yearly rates of seroprevalence. This study gives a crude estimate of the prevalence of HBV and HCV infections in the apparently healthy population of Northeast India.